Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute (A.S., S.L., S.V., S.V.A.), and Imaging Probe Development Center, National Heart, Lung and Blood Institute (N.R., R.E.S.), National Institutes of Health, Bethesda, Maryland.
Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute (A.S., S.L., S.V., S.V.A.), and Imaging Probe Development Center, National Heart, Lung and Blood Institute (N.R., R.E.S.), National Institutes of Health, Bethesda, Maryland
Drug Metab Dispos. 2019 Oct;47(10):1013-1023. doi: 10.1124/dmd.119.087734. Epub 2019 Aug 1.
Fluorescent conjugates of drugs can be used to study cellular functions and pharmacology. These compounds interact with proteins as substrates or inhibitors, helping in the development of unique fluorescence-based methods to study in vivo localization and molecular mechanisms. P-glycoprotein (P-gp, ABCB1) is an ATP-binding cassette (ABC) transporter that effluxes most anticancer drugs from cells, contributing to the development of drug resistance. To study the transport function of P-gp, we synthesized a Bodipy-labeled fluorescent conjugate of cyclosporine A (BD-CsA). After synthesis and characterization of its chemical purity, BD-CsA was compared with the commonly used 7-nitrobenz-2-oxa-1,3-diazol-4-yl (NBD)-CsA probe. In flow cytometry assays, the fluorescence intensity of BD-CsA was almost 10 times greater than that of NBD-CsA, enabling us to use significantly lower concentrations of BD-CsA to achieve the same fluorescence levels. We found that BD-CsA is recognized as a transport substrate by both human and mouse P-gp. The rate of efflux of BD-CsA by human P-gp is comparable to that of NBD-CsA. The transport of BD-CsA was inhibited by tariquidar, with similar IC values to those for NBD-CsA. BD-CsA and NBD-CsA both partially inhibited the ATPase activity of P-gp with similar IC values. In silico docking of BD-CsA and NBD-CsA to the human P-gp structure indicates that they both bind in the drug-binding pocket with similar docking scores and possibly interact with similar residues. Thus, we demonstrate that BD-CsA is a sensitive fluorescent substrate of P-gp that can be used to efficiently study the transporter's localization and function in vitro and in vivo. SIGNIFICANCE STATEMENT: The goal of this study was to develop an effective probe to study drug transport by P-glycoprotein (P-gp). Fluorophore-conjugated substrates are useful to study the P-gp transport mechanism, structural characteristics, and development of its inhibitors. Cyclosporine A (CsA), a cyclic peptide comprising 11 amino acids, is a known substrate of P-gp. P-gp affects CsA pharmacokinetics and interactions with other coadministered drugs, especially during transplant surgeries and treatment of autoimmune disorders, when CsA is given as an immunosuppressive agent. We synthesized and characterized Bodipy-FL-CsA as an avid fluorescent substrate that can be used to study the function of P-gp both in vitro and in vivo. We demonstrate that Bodipy-FL-conjugation does not affect the properties of CsA as a P-gp substrate.
荧光药物缀合物可用于研究细胞功能和药理学。这些化合物作为底物或抑制剂与蛋白质相互作用,有助于开发独特的基于荧光的方法来研究体内定位和分子机制。P-糖蛋白(P-gp,ABCB1)是一种ATP 结合盒(ABC)转运蛋白,可将大多数抗癌药物从细胞中排出,导致药物耐药性的产生。为了研究 P-gp 的转运功能,我们合成了环孢菌素 A(CsA)的 Bodipy 标记荧光缀合物(BD-CsA)。在合成和化学纯度表征后,将 BD-CsA 与常用的 7-硝基苯并-2-氧杂-1,3-二唑-4-基(NBD)-CsA 探针进行了比较。在流式细胞术测定中,BD-CsA 的荧光强度几乎是 NBD-CsA 的 10 倍,使我们能够使用浓度显著降低的 BD-CsA 来达到相同的荧光水平。我们发现 BD-CsA 被人源和鼠源 P-gp 识别为转运底物。人源 P-gp 对 BD-CsA 的外排率与 NBD-CsA 相当。BD-CsA 的转运被 tariquidar 抑制,其 IC 值与 NBD-CsA 相似。BD-CsA 和 NBD-CsA 均部分抑制 P-gp 的 ATP 酶活性,其 IC 值相似。BD-CsA 和 NBD-CsA 与 P-gp 结构的计算机对接表明,它们都结合在药物结合口袋中,具有相似的对接评分,并可能与相似的残基相互作用。因此,我们证明 BD-CsA 是 P-gp 的灵敏荧光底物,可用于有效地研究 P-gp 在体外和体内的定位和功能。意义陈述:本研究的目的是开发一种有效的探针来研究 P-糖蛋白(P-gp)的药物转运。荧光底物缀合物可用于研究 P-gp 的转运机制、结构特征及其抑制剂的开发。环孢菌素 A(CsA)是一种由 11 个氨基酸组成的环状肽,是 P-gp 的已知底物。P-gp 影响 CsA 的药代动力学和与其他同时给予的药物的相互作用,特别是在移植手术和治疗自身免疫性疾病期间,当 CsA 作为免疫抑制剂给予时。我们合成并表征了 Bodipy-FL-CsA 作为一种有效的荧光底物,可用于研究 P-gp 的功能,无论是在体外还是在体内。我们证明 Bodipy-FL 缀合不会影响 CsA 作为 P-gp 底物的性质。